Found: 30
Select item for more details and to access through your institution.
Thalassemia enters a new age ... And more lies ahead.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 3, p. 379, doi. 10.1002/ajh.26844
- By:
- Publication type:
- Article
Outcome of limited‐stage peripheral T‐Cell lymphoma after CHOP(−like) therapy: A population based study of 239 patients from the Nordic lymphoma epidemiology group.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 3, p. 388, doi. 10.1002/ajh.26803
- By:
- Publication type:
- Article
Overall and complication‐free survival in a large cohort of patients with β‐thalassemia major followed over 50 years.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 3, p. 381, doi. 10.1002/ajh.26798
- By:
- Publication type:
- Article
Idarubicin plus BuCy versus BuCy conditioning regimens for intermediate‐risk acute myeloid leukemia in first complete remission undergoing auto‐HSCT: An open‐label, multicenter, randomized phase 3 trial.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 3, p. 408, doi. 10.1002/ajh.26800
- By:
- Publication type:
- Article
A phase II study of combination d aunorubicin, cytarabine (A ra‐c), and nilotinib (TA signa) (DATA) in patients newly diagnosed with acute myeloid leukemia with KIT expression.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 3, p. 472, doi. 10.1002/ajh.26831
- By:
- Publication type:
- Article
Early‐onset reduced bone mineral density in patients with pyruvate kinase deficiency.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 3, p. E57, doi. 10.1002/ajh.26830
- By:
- Publication type:
- Article
Checkpoint inhibitor‐based salvage regimens prior to autologous stem cell transplant improve event‐free survival in relapsed/refractory classic Hodgkin lymphoma.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 3, p. 464, doi. 10.1002/ajh.26827
- By:
- Publication type:
- Article
Belantamab mafodotin induces immunogenic cell death within 24 h post‐administration in newly diagnosed multiple myeloma patients.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 3, p. E65, doi. 10.1002/ajh.26823
- By:
- Publication type:
- Article
The evolution of frontline therapy for adult Philadelphia‐positive acute lymphoblastic leukemia: Giant strides and ongoing challenges.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 3, p. 374, doi. 10.1002/ajh.26813
- By:
- Publication type:
- Article
Acute myeloid leukemia: 2023 update on diagnosis, risk‐stratification, and management.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 3, p. 502, doi. 10.1002/ajh.26822
- By:
- Publication type:
- Article
The international consensus classification of myeloid neoplasms and acute leukemias: Myeloproliferative neoplasms.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 3, p. 544, doi. 10.1002/ajh.26821
- By:
- Publication type:
- Article
Moving toward more molecular classifications of myelodysplastic syndrome and acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 3, p. 377, doi. 10.1002/ajh.26820
- By:
- Publication type:
- Article
The clinical relevance of detectable plasma iron species in iron overload states and subsequent to intravenous iron‐carbohydrate administration.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 3, p. 533, doi. 10.1002/ajh.26819
- By:
- Publication type:
- Article
Pregnancy outcomes in women with sickle cell disease in California.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 3, p. 440, doi. 10.1002/ajh.26818
- By:
- Publication type:
- Article
Frontline combination of ponatinib and hyper‐CVAD in Philadelphia chromosome‐positive acute lymphoblastic leukemia: 80‐months follow‐up results.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 3, p. 493, doi. 10.1002/ajh.26816
- By:
- Publication type:
- Article
Comparison of the International Consensus and 5th WHO edition classifications of adult myelodysplastic syndromes and acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 3, p. 481, doi. 10.1002/ajh.26812
- By:
- Publication type:
- Article
Common kinase mutations do not impact optimal molecular responses in core binding factor acute myeloid leukemia treated with fludarabine, cytarabine, and G‐CSF based regimens.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 3, p. E53, doi. 10.1002/ajh.26811
- By:
- Publication type:
- Article
Dynamic monitoring of minimal residual disease in newly‐diagnosed multiple myeloma.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 3, p. E61, doi. 10.1002/ajh.26810
- By:
- Publication type:
- Article
Targeting MCL‐1 and BCL‐2 with polatuzumab vedotin and venetoclax overcomes treatment resistance in R/R non‐Hodgkin lymphoma: Results from preclinical models and a Phase Ib study.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 3, p. 449, doi. 10.1002/ajh.26809
- By:
- Publication type:
- Article
Survival trends in young patients with Waldenström macroglobulinemia: Over five decades of experience.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 3, p. 432, doi. 10.1002/ajh.26807
- By:
- Publication type:
- Article
Thrombosis in multiple myeloma: Risk estimation by induction regimen and association with overall survival.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 3, p. 413, doi. 10.1002/ajh.26806
- By:
- Publication type:
- Article
Diagnostic and therapeutic challenges in mast cell sarcoma.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 3, p. 529, doi. 10.1002/ajh.26804
- By:
- Publication type:
- Article
Assessment of renal outcome following therapy in monoclonal immunoglobulin deposition disease: Emphasizing the need for a consensus approach.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 3, p. 421, doi. 10.1002/ajh.26801
- By:
- Publication type:
- Article
Bleeding with concomitant ibrutinib and oral anticoagulant therapy: A population‐based cohort study.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 3, p. E49, doi. 10.1002/ajh.26802
- By:
- Publication type:
- Article
Clinico‐genetic and prognostic analyses of 716 patients with primary myelodysplastic syndrome and myelodysplastic syndrome/acute myeloid leukemia based on the 2022 International Consensus Classification.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 3, p. 398, doi. 10.1002/ajh.26799
- By:
- Publication type:
- Article
Pearson syndrome.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 3, p. 527, doi. 10.1002/ajh.26794
- By:
- Publication type:
- Article
Impaired pro‐resolving mechanisms promote abnormal NETosis, fueling autoimmunity in sickle cell disease.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 3, p. E45, doi. 10.1002/ajh.26797
- By:
- Publication type:
- Article
Nitrous oxide misuse: Not a laughing matter.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 3, p. 541, doi. 10.1002/ajh.26649
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 3, p. 371, doi. 10.1002/ajh.26606
- Publication type:
- Article
CORRIGENDUM.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 3, p. 543, doi. 10.1002/ajh.26584
- Publication type:
- Article